Philips recognized as a Top 100 Global Innovator by Clarivate Analytics

Philips’ IntelliSpace Console advanced clinical decision support dashboard

AMSTERDAM, 29-Jan-2018 — /EuropaWire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it was named a 2017 Clarivate Analytics Top 100 Global Innovator. Clarivate Analytics’ (formerly known as the Thomson Reuters Intellectual Property & Science business) annual report highlights the world’s most successful organizations in terms of their active innovation through research and development, protection of intellectual property (IP), and the achievement of commercial success. Philips has been on this prestigious list for the last five years.

“We are pleased and honored to once again be recognized as a Top 100 Global Innovator by Clarivate Analytics, as it underlines our commitment to innovation,” said Frans van Houten, CEO Royal Philips. “Our EUR 1.7 billion global R&D program and strong intellectual property portfolio fuel our ability to deliver integrated solutions that improve people’s health and drive profitable growth for the company.”

We are pleased and honored to once again be recognized as a Top 100 Global Innovator by Clarivate Analytics, as it underlines our commitment to innovation.

Frans van Houten
CEO Royal Philips

According to Clarivate Analytics, placement on the list has become the standard measure for innovation across the world and is recognized as a significant achievement for those who are named. Clarivate Analytics celebrates innovative businesses that prioritize investment in unique and enduring inventions, and that have solidified their position by successfully bringing patents to market to benefit from their global commercial potential.

Clarivate Analytics’ methodology for determining the Top 100 Global Innovators is based on four principles: overall patent volume, patent application-to-grant success rate, global reach of the portfolio, and patent influence as evidenced by citations. The peer-reviewed methodology was executed using Clarivate analytics-powered solutions, including the Derwent World Patents Index (DWPI). The DWPI provides editorially enhanced, authoritative and accurate patent data, and is trusted by more than 40 patent offices worldwide. To view the full list of Top 100 Global Innovators and read the report on the 2017 Clarivate Analytics Top 100 Global Innovator program, go to

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 73,000 employees with sales and services in more than 100 countries. News about Philips can be found at

SOURCE: Koninklijke Philips N.V.


Steve Klink
Philips Group Press Office
Tel: +31 6 10888824


Comments are closed.